Contrasting associations of blood lipids with risk of myocardial infarction in Chinese and European adults
The findings reinforce current guidelines for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in China that advocate initiation of statin treatment in individuals at high-risk of ASCVD rather than high levels of LDL-C.
Authors
- Daniel Avery (ORCID: https://orcid.org/0000-0002-9823-9575)
- Canqing Yu (ORCID: https://orcid.org/0000-0002-0019-0014)
- Robert Clarke (ORCID: https://orcid.org/0000-0002-9802-8241)
- Dong Sun (ORCID: https://orcid.org/0000-0002-4546-404X)
- Christiana Kartsonaki (ORCID: https://orcid.org/0000-0002-3981-3418)
- Iona Y. Millwood (ORCID: https://orcid.org/0000-0002-0807-0682)
- Derrick Bennett (ORCID: https://orcid.org/0000-0002-9170-8447)
- Jun Lv (ORCID: https://orcid.org/0000-0001-7916-3870)
- Neil Wright (ORCID: https://orcid.org/0000-0002-3946-1870)
- Liming Li (ORCID: https://orcid.org/0000-0002-5798-2362)
- Wang Hanyu
- Zhengming Chen (ORCID: https://orcid.org/0000-0001-6423-105X)
- Shanpeng Li (ORCID: https://orcid.org/0000-0001-6667-2086)
- Michael Hill
- Robin Walters
Institutions
- Peking University (CN)
- University of Oxford (GB)
- Office of Readiness and Response (US)
- Ministry of Education (KR)
- Qingdao Municipal Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1093/ehjopen/oeaf119
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00